News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
FDA
Roche’s Avastin Rejected by U.K. Agency for Colorectal Cancer
November 12, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Bloomberg -- Roche Holding AG’s Avastin failed to win the backing of the U.K. National Institute for Health and Clinical Excellence for use in combination with chemotherapy against colorectal cancer that has spread.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Regulatory
Europe
Roche
MORE ON THIS TOPIC
Podcast
Tariffs Continue to Dominate Q1 Earnings, AACR Excites Cancer Space, CEO Pay Gaps, More
April 30, 2025
·
1 min read
·
Heather McKenzie
Rare diseases
Abeona Gets FDA Nod for Rare Skin Disease Gene Therapy
April 29, 2025
·
1 min read
·
Dan Samorodnitsky
Earnings
Regeneron Shares Tumble as Eylea Declines Make for a ‘Messy Quarter’ To Come
April 29, 2025
·
1 min read
·
Annalee Armstrong
Cancer
Summit, Akeso’s Keytruda Challenger Wins Chinese OK as US Approval Questions Linger
April 28, 2025
·
3 min read
·
Tristan Manalac
